210 related articles for article (PubMed ID: 24167657)
1. A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells.
Bao Z; Malki MI; Forootan SS; Adamson J; Forootan FS; Chen D; Foster CS; Rudland PS; Ke Y
Genes Cancer; 2013 Jul; 4(7-8):297-314. PubMed ID: 24167657
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid-binding protein 5 (FABP5)-related signal transduction pathway in castration-resistant prostate cancer cells: a potential therapeutic target.
Naeem AA; Abdulsamad SA; Rudland PS; Malki MI; Ke Y
Precis Clin Med; 2019 Oct; 2(3):192-196. PubMed ID: 35694437
[TBL] [Abstract][Full Text] [Related]
3. The expression of C-FABP and PPARγ and their prognostic significance in prostate cancer.
Forootan FS; Forootan SS; Malki MI; Chen D; Li G; Lin K; Rudland PS; Foster CS; Ke Y
Int J Oncol; 2014 Jan; 44(1):265-75. PubMed ID: 24189640
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.
Forootan FS; Forootan SS; Gou X; Yang J; Liu B; Chen D; Al Fayi MS; Al-Jameel W; Rudland PS; Hussain SA; Ke Y
Oncotarget; 2016 Feb; 7(8):9322-39. PubMed ID: 26814431
[TBL] [Abstract][Full Text] [Related]
5. The FABP12/PPARγ pathway promotes metastatic transformation by inducing epithelial-to-mesenchymal transition and lipid-derived energy production in prostate cancer cells.
Liu RZ; Choi WS; Jain S; Dinakaran D; Xu X; Han WH; Yang XH; Glubrecht DD; Moore RB; Lemieux H; Godbout R
Mol Oncol; 2020 Dec; 14(12):3100-3120. PubMed ID: 33031638
[TBL] [Abstract][Full Text] [Related]
6. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer.
Jing C; Beesley C; Foster CS; Rudland PS; Fujii H; Ono T; Chen H; Smith PH; Ke Y
Cancer Res; 2000 May; 60(9):2390-8. PubMed ID: 10811115
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.
Ohlsson G; Moreira JM; Gromov P; Sauter G; Celis JE
Mol Cell Proteomics; 2005 Apr; 4(4):570-81. PubMed ID: 15734831
[TBL] [Abstract][Full Text] [Related]
8. Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppression.
Morgan EA; Forootan SS; Adamson J; Foster CS; Fujii H; Igarashi M; Beesley C; Smith PH; Ke Y
Int J Oncol; 2008 Apr; 32(4):767-75. PubMed ID: 18360704
[TBL] [Abstract][Full Text] [Related]
9. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity.
Adamson J; Morgan EA; Beesley C; Mei Y; Foster CS; Fujii H; Rudland PS; Smith PH; Ke Y
Oncogene; 2003 May; 22(18):2739-49. PubMed ID: 12743598
[TBL] [Abstract][Full Text] [Related]
10. Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent.
Landrier JF; Thomas C; Grober J; Duez H; Percevault F; Souidi M; Linard C; Staels B; Besnard P
J Biol Chem; 2004 Oct; 279(44):45512-8. PubMed ID: 15337740
[TBL] [Abstract][Full Text] [Related]
11. Chicken adipocyte fatty acid-binding protein knockdown affects expression of peroxisome proliferator-activated receptor γ gene during oleate-induced adipocyte differentiation.
Shi H; Zhang Q; Wang Y; Yang P; Wang Q; Li H
Poult Sci; 2011 May; 90(5):1037-44. PubMed ID: 21489952
[TBL] [Abstract][Full Text] [Related]
12. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
13. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription.
Tan NS; Shaw NS; Vinckenbosch N; Liu P; Yasmin R; Desvergne B; Wahli W; Noy N
Mol Cell Biol; 2002 Jul; 22(14):5114-27. PubMed ID: 12077340
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins.
Schachtrup C; Emmler T; Bleck B; Sandqvist A; Spener F
Biochem J; 2004 Aug; 382(Pt 1):239-45. PubMed ID: 15130092
[TBL] [Abstract][Full Text] [Related]
15. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Th17 differentiation by epidermal fatty acid-binding protein.
Li B; Reynolds JM; Stout RD; Bernlohr DA; Suttles J
J Immunol; 2009 Jun; 182(12):7625-33. PubMed ID: 19494286
[TBL] [Abstract][Full Text] [Related]
17. Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine.
Poirier H; Niot I; Monnot MC; Braissant O; Meunier-Durmort C; Costet P; Pineau T; Wahli W; Willson TM; Besnard P
Biochem J; 2001 Apr; 355(Pt 2):481-8. PubMed ID: 11284737
[TBL] [Abstract][Full Text] [Related]
18. Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes.
McIntosh AL; Atshaves BP; Hostetler HA; Huang H; Davis J; Lyuksyutova OI; Landrock D; Kier AB; Schroeder F
Arch Biochem Biophys; 2009 May; 485(2):160-73. PubMed ID: 19285478
[TBL] [Abstract][Full Text] [Related]
19. N-3 PUFAs attenuate ischemia/reperfusion induced intestinal barrier injury by activating I-FABP-PPARγ pathway.
Wang X; Pan L; Lu J; Li N; Li J
Clin Nutr; 2012 Dec; 31(6):951-7. PubMed ID: 22554584
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte-fatty acid binding protein induces apoptosis in DU145 prostate cancer cells.
De Santis ML; Hammamieh R; Das R; Jett M
J Exp Ther Oncol; 2004 Jul; 4(2):91-100. PubMed ID: 15500004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
